Date 20170330
1700-1900 UTC
GoToMeeting Details
SNOMED Int'l Editorial Advisory group
SNOMED International - Editorial advisory group conference call
Thu, Mar 30, 2017 10:00 AM - 12:00 PM PDT
Please join my meeting from your computer, tablet or smartphone.
https://global.gotomeeting.com/join/465895349
You can also dial in using your phone.
United States: +1 (224) 501-3318
Access Code: 465-895-349
More phone numbers
Australia: +61 2 8355 1038
Belgium: +32 28 93 7002
Canada: +1 (647) 497-9373
Denmark: +45 32 72 03 69
Netherlands: +31 707 709 520
New Zealand: +64 9 913 2226
Spain: +34 932 75 1230
Sweden: +46 775 757 471
United Kingdom: +44 20 3713 5011
First GoToMeeting? Try a test session: http://help.citrix.com/getready
Observers:
Apologies
Meeting Files
Meeting minutes
Objectives
- Obtain consensus on agenda items
Discussion items
| Item | Description | Owner | Notes | Action | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Call to order and role call | JCA |
|
| ||||||||||
| 2 | Conflicts of interest | JCA | None. | |||||||||||
| 3 | Approval of minutes from 02/17/2017 | JCA |
| |||||||||||
| 4 | Drug Model deliverable review | TMO | Drug Model Editorial Guide | |||||||||||
| 5 | Substance redesign document review | JCA/TMO | Substance disposition proposal (see attached document) |
| ||||||||||
| 6 | Addition of "X disorder at Y level" | JCA | ICD-11 beta includes a large number of mostly injury concepts that specify the particular "level" or "segment" that an anatomical structure is affected. There is historical precedence for adding this type of content as some was orginally derived from ICD-9 and has been in SNOMED since before 2002.
| |||||||||||
| ECE Update | BGO | Update on ongoing issues with ECE | ||||||||||||
| "Presence"/"Absence": Situations or findings | Proposed policy on acceptance of "Patient-friendly terms" into the International release | JCA | There have been multiple requests from members to consider the addition of "Patient-friendly vocabulary". A draft document discussing the pros and cons and a proposed policy for inclusion of such terms in the International release is provided for discussion and input.
| |||||||||||
| Agenda items for London meeting | Group | |||||||||||||
| 10 |
|
|